Fallopian tube endometrioid adenocarcinoma
MONDO:0003666An adenocarcinoma that arises from the fallopian tube and resembles the endometrioid adenocarcinoma of the uterus. It usually has a favorable prognosis.
Also known as: endometrioid adenocarcinoma of fallopian tube, endometrioid adenocarcinoma of the fallopian tube, endometrioid carcinoma of fallopian tube, endometrioid carcinoma of the fallopian tube, fallopian tube endometrioid adenocarcinoma, fallopian tube endometrioid carcinoma
2877 clinical trials for this condition and its sub-types, 30 tagged with Fallopian tube endometrioid adenocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a 'Smart Bomb' drug outsmart recurrent ovarian cancer?
Disease control Not yet recruitingThis trial is testing whether a new drug called raludotatug deruxtecan (R-DXd), given alone or with bevacizumab, can help people with advanced ovarian cancer live longer and delay cancer growth compared to standard chemotherapy. The study includes adults with high-grade serous or…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for ovarian cancer: targeted drug combo takes on resistant tumors
Disease control Not yet recruitingThis phase II trial compares a new two-drug combination (sacituzumab govitecan plus bevacizumab) against standard chemotherapy (carboplatin, liposomal doxorubicin, and bevacizumab) in 87 women with platinum-sensitive ovarian cancer that has progressed after PARP inhibitor mainten…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC